PROCESS VALIDATION AND REGULATORY REQUIREMENTS OF METERED-DOSE INHALERS: AN OVERVIEW


Ashrani Sunil, Goyal Anju, Vaishnav Rajat

Abstract


 The goal of the validation is to assure that quality is built into the system at every step, and not just tested for at the end. The validation activities will commonly include training on production material and operating procedures, training of people involved, and monitoring of the system while in production. Each and every doses form needs to be validated to reduce the chances of batch failures and market recalls. In case of metered-dose inhalers (MDIs) also it becomes mandatory. US Food and Drug Administration defines process validation as “establishing documented evidence which provides a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality characteristics.” MDIs are known as device that is made to deliver a specific amount of aerosolized medication in the form of short burst directly to the lungs when inhaled by the patient. Furthermore, the inhalational drug delivery causes less pain and is convenient for administration. The patients of asthma, emphysema, and chronic obstructive pulmonary disease are prescribed for quicker relief. The present paper is a summary of process involved in the manufacturing of MDIs and focuses on the regulatory requirements along with their process validation.


Keywords


Metered-dose inhalers, Process validation, Chronic obstructive pulmonary disease, Bronchitis, etc.

| PDF |

References


Nag S, Gouthami B, Madhuri L, Reddy LV, Krishnaveni N, Meyyanathan SN, et al. The concept of process validation in tablet manufacturing: Review. J Pharm Res 2012;5:1264-7.

Sandhya C, Bonthagarala B, Sai PD, Sivaiah KV. Process validation: An essential process in pharmaceutical industry. Int J Agric Sci Res 2015;1:179-82.

Sharma M, Agarwal S, Agarwal S, Sharma M. Prospective validation: A review. Pharm Innov J 2015;4:1-7.

Nandhakumar L, Dharmamoorthy G, Rameshkumar S, Chandrasekaran S. An overview of pharmaceutical validation: Quality assurance view point. Int J Res Phys Chem 2011;1:1004-14.

Chaitanyakumar G, Rout RP, Ramtake S, Bhattacharya S. Process validation. Indian Pharm 2005;14-9.

U.S. Food and Drug Administration. Guideline on General Principles of Process Validation. Rockville, MD: U.S. FDA; 1987.

Akers J. Simplifying and improving process validation. J Parenter Sci Technol 2009;47:281-4.

Sharma S, Singh G. Process validation in pharmaceutical industry: An overview. J Drug Deliv Ther 2013;3:184-8.

Bai RR. Pharmaceutical validations. JPQA 2016;2:39-56.

Pattnaik SA, Niyogi P, Maharana L, Panigrahi L. Formulation, evaluation and solid-state thermographic characterization of CFC free beclometasone dipropionate pressurized metered dose inhalation. Int J Pharm Pharm Sci 2014;6:398-403.

Rajendran R, Balan R, Ganesan N, Thiruvengadam D. Recent modalities in drug delivery via inhalation therapy-an advanced treatment strategy for pulmonary carcinoma. Int J Pharm Pharm Sci 2015;7:8-21.

Kaur G, Rana AC, Seth N, Bala R. Process validation of metered dose inhaler: A review. Int Res J Pharm 2012;3:55-9.

Kumar GS, Gowrav MP. The newer dimension of inhalation aerosols in the prospective of validation. Int J Pharm Sci Res 2017;8:401-10.

Nash RA, Wachter AH. Pharmaceutical Process Validation. 3rd ed. New York: Marcel Dekker, Inc.; 2003.

Musale VP, Jagdale SC. A review on validation of pharmaceutical inhalation aerosols-pressurized metered dose inhaler (pMDI). Int J Pharm Sci Res 2016;6:336-44.

Shah D, Maheshwari D. Study of quality requirements of meter dose inhaler regulation in us and Europe. World J Pharm Pharm Sci 2015;4:623-34.




About this article

Title

PROCESS VALIDATION AND REGULATORY REQUIREMENTS OF METERED-DOSE INHALERS: AN OVERVIEW

Keywords

Metered-dose inhalers, Process validation, Chronic obstructive pulmonary disease, Bronchitis, etc.

DOI

10.22159/ajpcr.2018.v11i2.22408

Date

01-02-2018

Additional Links

Manuscript Submission

Journal

Asian Journal of Pharmaceutical and Clinical Research
Vol 11 Issue 2 February 2018 Page: 79-82

Print ISSN

0974-2441

Online ISSN

2455-3891

Authors & Affiliations

Ashrani Sunil
Department of Pharmaceutical Quality Assurance, M. Pharma Research Scholar, B.N. Institute of Pharmaceutical Sciences, Udaipur, Rajasthan, India.
India

Goyal Anju
Department of Pharmaceutical Chemistry, B.N. Institute of Pharmaceutical Sciences, Udaipur, Rajasthan, India.
India

Vaishnav Rajat
Department of Pharmaceutical Chemistry, B.N. Institute of Pharmaceutical Sciences, Udaipur, Rajasthan, India.
India


Article Tools


Email this article (Login required)
Email the author (Login required)

Refbacks

  • There are currently no refbacks.